Machine Learning–Based Prediction of Stroke and Systemic Embolism in Patients with Atrial Fibrillation: A Comparative Real-World Study

Jeffrey Chidumebi Nebonta *

Enugu State University of Science and Technology, Enugu State, Nigeria.

Chipuruime I. Ideh

Imo State University, College of Medicine, Owerri, Nigeria.

Benjamin O. C. Echendu

Vinnytsia National Pirogov Medical University, Ukraine.

Chimaobi Nwevo

NYC Health + Hospital/ South Brooklyn Health 11235, Brooklyn NY, USA.

*Author to whom correspondence should be addressed.


Abstract

Background: Risk stratification for ischaemic stroke and systemic embolism in atrial fibrillation (AF) typically relies on clinical scores with predefined predictors. This study compared conventional CHA₂DS₂-VASc scoring with logistic regression and machine learning models using routine clinical data.
Methods: A retrospective cohort of 248,500 adults with AF was identified in the TriNetX Global Collaborative Network from 2015 to 2025. Development and validation sets comprised 198,800 and 49,700 individuals, respectively. The primary outcome was ischaemic stroke or systemic embolism within 24 months. Discrimination, calibration, net benefit, and subgroup performance were evaluated.
Results: A total of 12,425 events were recorded (5.0% of the baseline cohort); 221,680 participants had ascertainable 24-month outcome status (event proportion, 5.6%). In the validation analysis, XGBoost achieved the highest AUROC (0.842; 95% CI, 0.832–0.852), followed by random forest (0.826), support vector machine (0.811), and logistic regression (0.794), compared with 0.681 for CHA₂DS₂-VASc. The XGBoost–CHA₂DS₂-VASc difference in AUROC was 0.161 (95% CI, 0.145–0.177; p < .001). XGBoost had a Brier score of 0.041 and higher estimated net benefit across the evaluated 2%–15% risk thresholds.
Conclusion: In this internal validation study, models incorporating multidimensional clinical data, particularly XGBoost, discriminated thromboembolic events more effectively than the conventional CHA₂DS₂-VASc score. The comparison highlights the potential contribution of clinical and laboratory variables to AF risk prediction; external validation remains necessary before clinical implementation.

Keywords: Atrial fibrillation, stroke, systemic embolism, machine learning, XGBoost, risk prediction, CHA₂DS₂-VASc.


How to Cite

Nebonta, Jeffrey Chidumebi, Chipuruime I. Ideh, Benjamin O. C. Echendu, and Chimaobi Nwevo. 2026. “Machine Learning–Based Prediction of Stroke and Systemic Embolism in Patients With Atrial Fibrillation: A Comparative Real-World Study”. Asian Journal of Cardiology Research 9 (1):662-76. https://doi.org/10.9734/ajcr/2026/v9i1414.

Downloads

Download data is not yet available.